Stocks and Investing Stocks and Investing
Tue, February 7, 2023

Joseph Pantginis Reiterated (ATNM) at Strong Buy and Held Target at $53 on, Feb 7th, 2023


Published on 2024-10-28 01:24:57 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Reiterated "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy and Held Target at $53 on, Feb 7th, 2023.

Joseph has made no other calls on ATNM in the last 4 months.



There is 1 other peer that has a rating on ATNM. Out of the 1 peers that are also analyzing ATNM, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Yuan Zhi of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $18 on, Monday, October 31st, 2022
Contributing Sources